A new study has found a connection between long-term metformin use among men with diabetes and lower colorectal cancer risk. Data of over 47,000 individuals was extracted from the Kaiser Permanente Norther California Diabetes Registry.… Read More
FRIDAY, April 15, 2016 (HealthDay News) — Metformin, a commonly prescribed diabetes drug, may reduce the risk of dying from some cancers for postmenopausal women with type 2 diabetes, a new study suggests.
The study found that for women… Read More
MONDAY, April 18, 2016 (HealthDay News) — Metformin, the most frequently prescribed standalone drug for type 2 diabetes, is better for the heart than its closest competitors, a large analysis suggests.
Metformin reduced the risk … Read More
The FDA has recently approved expanded labeling for diabetes drugs containing metformin. The new labels will now indicate that these medications can be used by some patients living with reduced kidney function. This change came after numerous… Read More
Researchers have recently found that metformin could reduce the possibility of mortality from certain cancers in postmenopausal women living with type 2 diabetes. These findings came after a review of data from about 146,000 postmenopausal… Read More
The diabetes drug metformin may also lower the risk of lung cancer – but only for those who don’t smoke.
Smokers, on the other hand, saw an increased risk of lung cancer while taking metformin, which helps control blood sugar levels in diabetes… Read More